COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • March 16th, 2021 • Merus N.V. • Pharmaceutical preparations • New York
This Collaboration and License Agreement (“Agreement”) is entered into as of January 18, 2021 (the “Effective Date”) by and between Merus N.V., a corporation organized and existing under the laws of the Netherlands and having an address at Yalelaan 62, 3584 CM Utrecht, The Netherlands (“Merus”), and Eli Lilly and Company, a corporation organized and existing under the laws of Indiana, with its principal business office located at Lilly Corporate Center, Indianapolis, Indiana 46285, U.S.A. (“Lilly”). Lilly and Merus are each hereafter referred to individually as a “Party” and together as the “Parties.”
